Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder

Research output: Contribution to journalArticle

59 Scopus citations

Abstract

The controversy over the use of imipramine and other tricyclics in the treatment of attention deficit disorder (ADD), is examined, and all available literature is critically reviewed. Although both stimulants and antidepressants ameliorate ADD symptoms, the bulk of the literature suggests that overall, stimulants are superior to imipramine in the treatment of ADD. There may, however, be a subgroup of children with ADD who respond better to imipramine, and this group may be one characterized by higher levels of anxiety or depression or both.

Original languageEnglish (US)
Pages (from-to)127-132
Number of pages6
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume26
Issue number2
DOIs
StatePublished - Jan 1 1987

Keywords

  • attention deficit disorder
  • tricyclic antidepressants

ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder'. Together they form a unique fingerprint.

  • Cite this